Morgan Stanley Maintains Overweight on Lam Research, Lowers Price Target to $339
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and lowers the price target from $385 to $339.
Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and lowers the price target from $385 to $339.